TGFB1 and neoplasm: For each of the immune response signatures examined, even in the case of significantly high expression, the coexistence of a highly expressed TGF-β signature (and which corresponds to the tumor profile in our models after treatment with the CDDP-Eri combination) then abolished the favorable prognostic effect.